| Literature DB >> 33928404 |
Anna Herrera-Chacón1, Xavier Cetó1, Manel Del Valle2.
Abstract
Molecularly imprinted polymers (MIPs) are artificially synthesized materials to mimic the molecular recognition process of biological macromolecules such as substrate-enzyme or antigen-antibody. The combination of these biomimetic materials with electrochemical techniques has allowed the development of advanced sensing devices, which significantly improve the performance of bare or catalyst-modified sensors, being able to unleash new applications. However, despite the high selectivity that MIPs exhibit, those can still show some cross-response towards other compounds, especially with chemically analogous (bio)molecules. Thus, the combination of MIPs with chemometric methods opens the room for the development of what could be considered a new type of electronic tongues, i.e. sensor array systems, based on its usage. In this direction, this review provides an overview of the more common synthetic approaches, as well as the strategies that can be used to achieve the integration of MIPs and electrochemical sensors, followed by some recent examples over different areas in order to illustrate the potential of such combination in very diverse applications.Entities:
Keywords: Electronic tongue; Immobilization; Molecular imprinting; Molecularly imprinted polymers (MIPs); Polymerization; Voltammetric sensors
Mesh:
Substances:
Year: 2021 PMID: 33928404 PMCID: PMC8084593 DOI: 10.1007/s00216-021-03313-8
Source DB: PubMed Journal: Anal Bioanal Chem ISSN: 1618-2642 Impact factor: 4.142
Fig. 1Schematic representation of the synthesis of biomimetic artificial receptors: (A) molecularly imprinted polymer (MIP) and (B) non-imprinted polymer (NIP)
Fig. 2Diagram of the main imprinting methods: a Covalent and semi-covalent imprinting, b metal-ion exchange imprinting and c non-covalent imprinting
Summary of the main advantages and disadvantages of the more common polymerization methods
| Polymerization method | Advantages | Disadvantages | Example of reported (bio)sensing applications |
|---|---|---|---|
| Bulk | Simple and cost-effective | Harsher template removal and heterogeneity in particle size distribution and/or cavities | [ |
| Precipitation | Quick synthesis and easier template removal with high yields | Diluted reagents media producing heterogeneous cavities | [ |
| Emulsion | Small nanoMIPs | Emulsifier agent needed, adding an extra synthesis step | [ |
| Core-shell | Dual property material with outer imprinted layer (silica, metallic or magnetic) | Inefficient imprinting if outer layer is too thin | [ |
Fig. 3Confocal microscopy assay to confirm the imprinting effect on the MIP in respect to the NIP. Images of (a) MIP and (b) NIP particles after incubation with histamine and reaction with o-phthaldialdehyde (OPA), which yields a maximum fluorescence at 455 nm upon excitation at 340 nm. (c) Background fluorescence of the MIP particles when not incubated with histamine, but reacted with OPA, as negative control. (d) Fluorescence intensity of the previous in arbitrary units. Reproduced with permission from Elsevier [48]
Fig. 4Representation of the immobilization of the MIP particles either by drop-casting or spin coating
Fig. 5Schematic of the steps involved in the surface-initiated polymerization. Briefly, the iniferter (which acts as the initiator, transfer agent and terminator) is electrografted to the sensor surface, which is followed by the addition of the solution containing the functional monomer(s), cross-linking agents and template, and the photopolymerization of the monomers under UV irradiation. Reproduced with permission from Estonian Academy Publishers [74]
Fig. 6Schematic of the sensing approach for S. aureus sensing based on an electropolymerized MIP for 3-thiopheneacetic acid and its determination by EIS measurements of the blockage upon rebinding with [Fe(CN)6]3/4− as the redox probe. Reproduced with permission from Elsevier [76]
Fig. 7Schematic of the fabrication and detection principle of the voltammetric MIP-based sensor towards PSA. Briefly, the GCE was modified with a graphene nanosheet-gold nanoparticles (GS-Au) solution, followed by the deposition of chitosan (CS). Next, it was activated with glutaraldehyde (GA) to achieve the covalent immobilization of PSA through an imine bond between the two. Lastly, dopamine was electropolymerized to obtain the in situ MIP after removal of PSA by immersion in an acetic acid solution. Reproduced with permission from Springer [77]
Survey of diverse applications in different fields employing different types of MIP-based electrochemical sensors
| Analyte | Sample1 | Sample1 | Polymerization method | Immobilization | Electrochemical technique2 | Electrode type3 | Linear range | LOD4 | Ref.5 |
|---|---|---|---|---|---|---|---|---|---|
| Environmental | |||||||||
| 4-Aminophenol | Water | Spike | Precipitation | Nafion | Amp | GCE | 10.0 to 90.0 μM | 3 μM | [ |
| Bisphenol A (BPA) | Buffer | – | Precipitation | Entrapment into ink/composite | CV | GSPE | 0 to 410 ng·L−1 | 13 ng·L−1 | [ |
| Bisphenol A (BPA) | Plastic samples | Real | Precipitation | PVC membrane | Pot | Graphite paper | 0.5 to 13 μM | 0.15 μM | [ |
| Cefalexin | Water | Spike | In situ electropolymerization | – | DPV | GCE/BDDE | 10 to 100 nM | 4.9/3.2 nM | [ |
| Cu(II) | Water | Spike | Suspension | SAM of cysteamine and carbodiimide cross-linker chemistry | DPV | AuSPE | 1.9 to 61 nM | 74 pM | [ |
| 17β-Estradiol | Water | Spike | In situ electropolymerization | – | LSV | Au | 3.6 fM to 3.6 nM | 1.09 fM | [ |
| Furazolidone | Water | Spike | Precipitation | Entrapment into composite electrode | DPV | CPE | 0.01 to 1 μM | 0.03 μM | [ |
| Mn(II) | Water | Spike | Precipitation | Chitosan | SWASV | GCE | 2.0 to 9.0 μM | 0.15 μM | [ |
| Methidathion | Water | Spike | Bulk | Sol-gel | EIS | GSPE | 40 to 200 μg·L−1 | 5.14 μg·L−1 | [ |
| | Water | Spike | Bulk | Electropolymerization of pyrrole | EIS | GCE | 10 to 230 μg·L−1 | 0.85 μg·L−1 | [ |
| Food control | |||||||||
| 4-Ethylphenol | Buffer | – | Precipitation | Sol-Gel | DPV | GEC | 5 to 35 μg·L−1 | 1.33 μg·L−1 | [ |
| 4-Ethylguaiacol | Buffer | – | Precipitation | Sol-Gel | DPV | GEC | 3 to 21 μg·L−1 | 1.55 μg·L−1 | [ |
| Histamine | Fish | Spike | Magnetic core-shell | Magneto-capture | CV | GEC | 0 to 2.2·104 mg·L−1 | 1.6·10−6 mg·L−1 | [ |
| Histamine | Wine | Real | Precipitation | Sol-gel | DPV | GEC | 0.5 to 6.0 μg·L−1 | 0.19 μg·L−1 | [ |
| Lactose | Milk | Real | In situ electropolymerization | – | DPV | Graphite paper | 1.0 to 10 nM | 0.88 nM | [ |
| Melamine | Milk | Spike | In situ photopolymerization | – | SWV | Au | 10−9 to 10−7 M | 7.71·10−10 M | [ |
| Prostate-specific antigen (PSA) | Serum | Real | In situ electropolymerization | – | DPV | GCE | 1 pg·mL−1 to 100 ng·mL−1 | 0.15 pg·mL−1 | [ |
| Sulfamethazine | Milk | Spike | Bulk | None | SWV | GCE | 2.0·10−6 to 4.0·10−4 M | 3.0·10−7 M | [ |
| Theophylline | Buffer | – | Precipitation | Sol-gel | DPV | GEC | – | 1 μM | [ |
| Tryptophan | Milk, serum and pharmaceutical | Spike/real | Precipitation | Nafion | DPV | GCE | 6.0·10−8 to 4.0·10−5 M | 7.1 nM | [ |
| | Milk | Spike | In situ electropolymerization | – | EIS | Au | 0 to 108 CFU·ml−1 | 2 CFU·mL−1 | [ |
| Clinical diagnostics | |||||||||
| Artemisinin | Human serum and plant extracts | NA | In situ electropolymerization | – | CV/SWV | Au | 0.01 to 1.36 μM | 0.01 μM | [ |
| Brain-derived neurotrophic factor (BDNF) | Buffer | – | In situ photopolymerization | – | DPV | AuSPE | 0.01 to 0.06 ng·mL−1 | 6 pg·mL−1 | [ |
| Bisoprolol fumarate | Pharmaceutical, urine and blood | Real | Bulk | Entrapment into composite electrode | Pot | CPE | 1.0·10−7 to 1.0·10−2 M | 5.0·10−8 M | [ |
| C4-HSL | Buffer | – | Bulk/SPE | SAM of cysteamine and carbodiimide cross-linker chemistry | DPV | AuSPE | 6.25 to 800 nM | 0.12 nM | [ |
| Daptomycin | Human serum | Spiked | In situ electropolymerization | – | DPV | GCE | 1 to 20 pM | 0.161 pM | [ |
| Digoxin | Human blood serum and pharmaceutical | Spike | Bulk | Entrapment into composite electrode | EIS | CPE | 1.0·10−9 to 0.5 10−7 M | 6.95·10−11 M | [ |
| Dopamine/ascorbic acid | Serum | NA | FRP | DPC | GSPE | 100 to 500 nM | – | [ | |
| Doxycycline | Pharmaceutical preparations | Real | Bulk | PVC membrane | Pot | Perspex | 7.99·10−6 M to - | 3.55 μg·mL−1 | [ |
| Ephedrine | Buffer | – | Precipitation | CV | GCE | 0.5 to 3 mM | – | [ | |
| Ferritin | Urine | Spike and Real | In situ electropolymerization | – | CV | Au | 40 to 360 mg·dm−3 | 10.7 mg·dm−3 | [ |
| Glucose | Buffer | – | Bulk/SPE | SAM of cysteamine and carbodiimide cross-linker chemistry | DPV | AuSPE | 0.8 to 50 mM | 0.43 mM | [ |
| Human serum albumin (HSA) | Urine | Spike and real | In situ electropolymerization | – | CV | Au | 20 to 100 mg·dm−3 | 3.7 mg·dm−3 | [ |
| Levothyroxine hormone | Synthetic samples | Spike | Magnetic core-shell | Direct magneto immobilization | LSV | GEC | 3.88·10−6 to 388.4 μg·mL−1 | 0.0356 ng·mL−1 | [ |
| Methocarbamol | Human plasma | Spike | Precipitation | None | DPV | GCE | 0.10 to 15.0 μg·mL−1 | 0.025 μg·mL−1 | [ |
| Metronidazole | Human serum and urine | Spike | Bulk | Entrapment into composite electrode | DPV | CPE | 5.64·10−5 to 2.63·10−3 mg·L−1 | 3.59·10−5 mg·L−1 | [ |
| Naloxone | Urine/serum | Spike | In situ electropolymerization | – | DPV | GSPE | 0.25 to 10 μM | 0.20 μM | [ |
| Paracetamol | Pharmaceutical | Spike | In situ electropolymerization | – | DPV | PGE | 5 μM to 0.50 mM | 7.9·10−7 M | [ |
| Paracetamol | Buffer | – | Bulk/SPE | SAM of cysteamine and carbodiimide cross-linker chemistry | DPV | AuSPE | 100 to 1000 μM | 82 μM | [ |
| SARS-CoV-2 antigen | Lysis buffer | Spike and real | In situ electropolymerization | – | DPV | Au | 2.22 to 111 fM | 15 fM | [ |
| Trypsin | Buffer | – | Solid-phase method | Electropolymerization of tyramine, followed by glutaraldehyde | Cap | Au | 1·10−14 to 1·10−9 M | 1·10−14 M | [ |
| Trypsin | Buffer | – | Bulk/SPE | SAM of cysteamine and carbodiimide cross-linker chemistry | DPV | AuSPE | 6.5 to 100 nM | 0.20 nM | [ |
| Homeland security and forensic | |||||||||
| Cocaine | Saliva, river water and street samples | Spike | In situ electropolymerization | – | SWV | GphSPE | 100 to 500 μM | 50 μM | [ |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Plasma and urine | Spike | In situ electropolymerization | – | SWV | GSPE | 2.6 to 200 μM | 0.79 μM | [ |
| Morphine | Buffer | – | Precipitation | Electropolymerization of PEDOT | Amp | ITO | 0.1 to 2 mM | 0.3 mM | [ |
| Tetrahydrocannabinol (THC) | Buffer | – | Solid-phase method | Electropolymerization of tyramine, followed by glutaraldehyde | Cap | Au | 1·10−12 to 1·10−5 M | 1·10−14 M | [ |
| Tetrahydrocannabinol (THC) | Buffer | – | Bulk/SPE | SAM of cysteamine and carbodiimide cross-linker chemistry | DPV | AuSPE | 0.1 to 1000 μM | 0.05 μM | [ |
| 2,4,6-Trinitrotoluene (TNT) | Buffer | – | In situ electropolymerization | – | CV | Au | 0.1 to 10 nM | 50 pM/100 pM | [ |
| RDX (1,3,5-trinitroperhydro-1,3,5-triazine) | Buffer | – | In situ electropolymerization | – | CV | Au | 0.1 to 10 nM | 100 pM | [ |
1“Buffer” refers to sensors that have only been tested in buffered media with stock solutions, “spiked” to sensors that have been tested in spiked real samples, “real” to sensors which performance has been satisfactorily validated in real samples, and “NA” to sensors that were tested in real samples, but its performance not benchmarked
2Amp, amperometry at fix potential; Cap, capacitive via current pulse method; CV, cyclic voltammetry; DPC, double-pulse chronoamperometry; DPV, differential pulse voltammetry; EIS, electrochemical impedance spectroscopy; LSV, linear sweep voltammetry; Pot, potentiometric; SWV, square wave voltammetry; SWASV, square wave anodic stripping voltammetric
3AuSPE, gold screen-printed electrode; BDDE, boron-doped diamond electrode; CPE, carbon paste electrode; GCE, glassy carbon electrode; GEC, graphite-composite electrode; GphSPE, graphene screen-printed electrode; GSPE, graphite screen-printed electrode; ITO, indium tin oxide; PGE, pencil graphite electrode
4LOD, limit of detection
5Ref, reference
Fig. 8Schematic representation of the main steps involved in the development of a MIP-based potentiometric sensor for the determination of bisphenol A (BPA). Briefly, the process starts coating chromatography paper with a carbon ink, followed by its coating with an adhesive plastic. Finally, the membrane cocktail containing the MIP particles was drop-casted onto the build sensor surface. Reproduced with permission from Royal Society of Chemistry [83]
Fig. 9Schematic illustration of the pre-concentration and electrochemical sensing of histamine based on the usage of a magnetic-MIP and a magnetic-GEC electrode. Reproduced with permission from Elsevier [86]
Fig. 10Schematic representation of the main steps involved in the development of a MIP-based voltammetric sensor for the determination of lactose. Briefly, the process starts with the electropolymerization of pyrrole in the presence of lactose. Next, the template is removed by overoxidation in a NaOH solution, leaving three-dimensional imprinted cavities complementary to the template. Sensing is based on the measurement of pore blockage with [FE(CN)6]3− upon rebinding of lactose when the sensor is incubated with the samples. Reproduced with permission from Elsevier [84]
Fig. 11Schematic of the steps of the COVID-19 diagnostics principle by ncovNP sensor analysing the samples prepared from nasopharyngeal swab specimens of patients, and of the electrochemical measurement based on pore blockage of the [Fe(CN)6]4−. Reproduced with permission from Elsevier [94]
Fig. 12(Top) Schematic representation of the response principle of the MIP-based sensor. Briefly, the rebinding of the analyte to the MIP triggers a detectable change in the polymer conformation thanks to the ferrocene that is incorporated into the polymeric matrix. (Bottom) Scanning electron microscopy images of the synthetized MIPs for paracetamol detection. Reproduced with permission from Springer [71]
Fig. 13Schematic representation of the steps involved in the ET approach reported by Herrera-Chacon et al. [59]. Briefly, the set of samples are measured with the MIP-based sensor array, collecting a whole voltammogram for each of the samples. Next, the data is processed by means of PCA to achieve the discrimination of the different volatile phenols or ANNs for the quantification of volatile phenols mixtures